Literature DB >> 21788723

Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan.

Hikaru Kume1, Toshikazu Yamazaki, Tomiteru Togano, Michiko Abe, Hiroyuki Tanuma, Seiji Kawana, Masahiko Okudaira.   

Abstract

The data on visceral mycoses reported in the " Annual of Pathological Autopsy Cases in Japan " were analyzed epidemiologically every four years from 1989 to 2005, and in 2007. The frequency rates of visceral mycoses dropped sharply between 1989 (4.5%) and 1994 (3.2%), but by 2001 had risen again and have remained (4.4-4.6%) generally stable since then. The predominant causative agents were Candida and Aspergillus. Although the rate of candidosis showed a gradual decrease, the rate of aspergillosis showed an increase by degrees. Furthermore, the rate of aspergillosis exceeded that of candidosis in 1994, and the difference in the rates between the two conditions apparently further increased until 2001. After 2005, however no changes in this difference were observed. For complicated infections, the incidence of coinfection with Aspergillus and Candida showed a decreasing, and that with Aspergillus and Zygomycetes showed an increasing tendency. Severe infections with Zygomycetes showed a clear increase from 57.4% in 1989 to 88.9% in 2007. Comparing underlying diseases with mycoses in 1989 and 2007, leukemia (including myelodysplastic syndrome) decreased from 26.1% to 18.8% and bacterial infections (including interstitial pneumonia) increased from 11.1% to 22.1%. By age, the highest frequency rate of mycoses was observed in the range of 60-79 years, and the frequency rate of exogenous fungal infections such as aspergillosis, cryptococcosis, zygomycosis and trichosporonosis showed an increasing trend in the less than one-year old group.

Entities:  

Mesh:

Year:  2011        PMID: 21788723     DOI: 10.3314/jjmm.52.117

Source DB:  PubMed          Journal:  Med Mycol J


  17 in total

1.  Clinical Spectrum, Diagnosis and Outcome of Rare Fungal Infections in Patients with Hematological Malignancies: Experience of 15-Year Period from a Single Tertiary Medical Center.

Authors:  Emilia Hardak; Eyal Fuchs; Yuval Geffen; Tsila Zuckerman; Ilana Oren
Journal:  Mycopathologia       Date:  2020-02-25       Impact factor: 2.574

2.  Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study.

Authors:  G Maschmeyer; W J Heinz; B Hertenstein; H-A Horst; C Requadt; T Wagner; O A Cornely; J Löffler; M Ruhnke
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-12-28       Impact factor: 3.267

Review 3.  [Identification of fungal pathogens in tissue samples using fluorescence in situ hybridization].

Authors:  V Rickerts
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

4.  Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.

Authors:  Masato Tashiro; Koichi Izumikawa; Asuka Minematsu; Katsuji Hirano; Naoki Iwanaga; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

5.  Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus.

Authors:  Masato Tashiro; Koichi Izumikawa; Katsuji Hirano; Shotaro Ide; Tomo Mihara; Naoki Hosogaya; Takahiro Takazono; Yoshitomo Morinaga; Shigeki Nakamura; Shintaro Kurihara; Yoshifumi Imamura; Taiga Miyazaki; Tomoya Nishino; Misuzu Tsukamoto; Hiroshi Kakeya; Yoshihiro Yamamoto; Katsunori Yanagihara; Akira Yasuoka; Takayoshi Tashiro; Shigeru Kohno
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

6.  Invasive Fungal Disease in Patients with Chronic Lymphocytic Leukemia in Japan: A Retrospective Database Study.

Authors:  Takeo Yasu; Kotono Sakurai; Manabu Akazawa
Journal:  Curr Oncol       Date:  2022-05-04       Impact factor: 3.109

7.  Development of a peptide nucleic acid probe to Trichosporon species and identification of trichosporonosis by use of in situ hybridization in formalin-fixed and paraffin-embedded (FFPE) sections.

Authors:  Minoru Shinozaki; Yoichiro Okubo; Daisuke Sasai; Haruo Nakayama; Somay Yamagata Murayama; Tadashi Ide; Megumi Wakayama; Takao Ishiwatari; Naobumi Tochigi; Tetsuo Nemoto; Kazutoshi Shibuya
Journal:  J Clin Microbiol       Date:  2012-10-24       Impact factor: 5.948

8.  Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies.

Authors:  Mitsutoshi Kurosawa; Masakatsu Yonezumi; Satoshi Hashino; Junji Tanaka; Mitsufumi Nishio; Makoto Kaneda; Shuichi Ota; Kyuhei Koda; Nobuhiro Suzuki; Makoto Yoshida; Yasuo Hirayama; Rishu Takimoto; Yoshihiro Torimoto; Akio Mori; Tohru Takahashi; Susumu Iizuka; Tadao Ishida; Ryoji Kobayashi; Takanori Oda; Hajime Sakai; Satoshi Yamamoto; Fumihiko Takahashi; Takashi Fukuhara
Journal:  Int J Hematol       Date:  2012-10-31       Impact factor: 2.490

9.  Invasive fungal disease in university hospital: a PCR-based study of autopsy cases.

Authors:  Komkrit Ruangritchankul; Ariya Chindamporn; Navaporn Worasilchai; Ubon Poumsuk; Somboon Keelawat; Andrey Bychkov
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

10.  A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis.

Authors:  S Kohno; K Izumikawa; M Yoshida; Y Takesue; S Oka; K Kamei; Y Miyazaki; T Yoshinari; N A Kartsonis; Y Niki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.